Catalyst Pharmaceutical (CPRX) PT Raised to $24 at Truist Securities on Vamorolone opportunity
Tweet Send to a Friend
(Updated - June 20, 2023 11:45 AM EDT)
Truist Securities analyst Joon Lee raised the price target on Catalyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Joon Lee raised the price target on Catalyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
